|
US4057685A
(en)
|
1972-02-02 |
1977-11-08 |
Abbott Laboratories |
Chemically modified endotoxin immunizing agent
|
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
|
US4459286A
(en)
|
1983-01-31 |
1984-07-10 |
Merck & Co., Inc. |
Coupled H. influenzae type B vaccine
|
|
US4663160A
(en)
|
1983-03-14 |
1987-05-05 |
Miles Laboratories, Inc. |
Vaccines for gram-negative bacteria
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4761283A
(en)
|
1983-07-05 |
1988-08-02 |
The University Of Rochester |
Immunogenic conjugates
|
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US4882317A
(en)
|
1984-05-10 |
1989-11-21 |
Merck & Co., Inc. |
Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
|
|
US4695624A
(en)
|
1984-05-10 |
1987-09-22 |
Merck & Co., Inc. |
Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
|
|
US4808700A
(en)
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
|
IT1187753B
(it)
|
1985-07-05 |
1987-12-23 |
Sclavo Spa |
Coniugati glicoproteici ad attivita' immunogenica trivalente
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
US5011828A
(en)
|
1985-11-15 |
1991-04-30 |
Michael Goodman |
Immunostimulating guanine derivatives, compositions and methods
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US5206152A
(en)
|
1988-04-08 |
1993-04-27 |
Arch Development Corporation |
Cloning and expression of early growth regulatory protein genes
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
NL8802046A
(nl)
|
1988-08-18 |
1990-03-16 |
Gen Electric |
Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
|
|
AU631377B2
(en)
|
1988-08-25 |
1992-11-26 |
Liposome Company, Inc., The |
Affinity associated vaccine
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
|
ES2055785T3
(es)
|
1989-01-17 |
1994-09-01 |
Eniricerche Spa |
Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
|
|
EP0832980B1
(en)
|
1989-01-23 |
2002-06-19 |
Chiron Corporation |
Recombinant therapies for infection and hyperproliferative disorders
|
|
CA2357538A1
(en)
|
1989-03-21 |
1990-10-04 |
Wisconsin Alumni Research Foundation |
Expression of exogenous polynucleotide sequences in a vertebrate
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
FI920131A0
(fi)
|
1989-07-14 |
1992-01-13 |
Praxis Biolog Inc |
Cytokin- och hormonbaerare foer konjugatvaccin.
|
|
AU648261B2
(en)
|
1989-08-18 |
1994-04-21 |
Novartis Vaccines And Diagnostics, Inc. |
Recombinant retroviruses delivering vector constructs to target cells
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US4988815A
(en)
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
ZA911974B
(en)
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
|
US5658731A
(en)
|
1990-04-09 |
1997-08-19 |
Europaisches Laboratorium Fur Molekularbiologie |
2'-O-alkylnucleotides as well as polymers which contain such nucleotides
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
US5149655A
(en)
|
1990-06-21 |
1992-09-22 |
Agracetus, Inc. |
Apparatus for genetic transformation
|
|
GB2276169A
(en)
|
1990-07-05 |
1994-09-21 |
Celltech Ltd |
Antibodies specific for carcinoembryonic antigen
|
|
DE69113564T2
(de)
|
1990-08-13 |
1996-05-30 |
American Cyanamid Co |
Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
|
|
NZ239643A
(en)
*
|
1990-09-17 |
1996-05-28 |
North American Vaccine Inc |
Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
|
|
CA2098849C
(en)
|
1990-12-20 |
2007-07-10 |
Ralph R. Weichselbaum |
Control of gene expression by ionizing radiation
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
UA32546C2
(uk)
|
1991-03-01 |
2001-02-15 |
Міннесота Майнінг Енд Мен'Юфекчурінг Компані |
1,2-заміщені 1н-імідазо[4,5-с]хінолін-4-аміни, проміжні сполуки для їх синтезу, антивірусна фармацевтична композиція, спосіб лікування інфікованих ссавців, спосіб індукування біосинтезу інтерферону у ссавців, спосіб уповільнення росту бластом
|
|
CA2115742A1
(en)
|
1991-08-20 |
1993-03-04 |
Ronald G. Crystal |
Adenovirus mediated transfer of genes to the gastrointestinal tract
|
|
US5936076A
(en)
|
1991-08-29 |
1999-08-10 |
Kirin Beer Kabushiki Kaisha |
αgalactosylceramide derivatives
|
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
JPH07507689A
(ja)
|
1992-06-08 |
1995-08-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
特定組織のターゲティング方法及び組成物
|
|
EP0644946A4
(en)
|
1992-06-10 |
1997-03-12 |
Us Health |
VECTOR PARTICLES RESISTANT TO HUMAN SERUM INACTIVATION.
|
|
EP0671948B1
(en)
|
1992-06-25 |
1997-08-13 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Vaccine composition containing adjuvants
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
JPH08503855A
(ja)
|
1992-12-03 |
1996-04-30 |
ジェンザイム・コーポレイション |
嚢胞性線維症に対する遺伝子治療
|
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
|
ES2109685T5
(es)
|
1993-03-23 |
2005-09-01 |
Smithkline Beecham Biologicals S.A. |
Composiciones para vacunas que contienen monofosforil-lipido a 3-o-desacilado.
|
|
US5759573A
(en)
|
1993-04-22 |
1998-06-02 |
Depotech Corporation |
Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
|
|
AU687829B2
(en)
|
1993-06-24 |
1998-03-05 |
Advec, Inc. |
Adenovirus vectors for gene therapy
|
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
ATE195735T1
(de)
|
1993-07-15 |
2000-09-15 |
Minnesota Mining & Mfg |
Imidazo (4,5-c)pyridin-4-amine
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
CA2158937C
(en)
|
1993-09-15 |
2006-01-03 |
Thomas W. Dubensky, Jr. |
Recombinant alphavirus vectors
|
|
JP3875990B2
(ja)
|
1993-10-25 |
2007-01-31 |
カンジ，インコーポレイテッド |
組換えアデノウイルスベクターおよび使用方法
|
|
WO1995011700A1
(en)
|
1993-10-29 |
1995-05-04 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
|
DK0729351T3
(da)
|
1993-11-16 |
2000-10-16 |
Skyepharma Inc |
Vesikler med reguleret afgivelse af aktivstoffer
|
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
DE69535669T2
(de)
|
1994-05-09 |
2008-12-04 |
Oxford Biomedica (Uk) Ltd. |
Retrovirale vektoren mit verminderter rekombinationsrate
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
|
WO1996017072A2
(en)
|
1994-11-30 |
1996-06-06 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
ATE424463T1
(de)
|
1996-05-06 |
2009-03-15 |
Oxford Biomedica Ltd |
Rekombinationsunfähige retrovirale vektoren
|
|
US5770208A
(en)
|
1996-09-11 |
1998-06-23 |
Nabi |
Staphylococcus aureus B-linked hexosamine antigen
|
|
EP2172216A3
(en)
|
1997-03-10 |
2010-11-24 |
Ottawa Hospital Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
WO1999005167A1
(en)
|
1997-07-25 |
1999-02-04 |
University Of Massachusetts |
Designed protein pores as components for biosensors
|
|
EP0905243A2
(en)
*
|
1997-08-05 |
1999-03-31 |
Smithkline Beecham Corporation |
Polynucleotides from Staphylococcus aureus expressed in infected tissue
|
|
DE69838992T2
(de)
|
1997-09-05 |
2008-12-24 |
Glaxosmithkline Biologicals S.A., Rixensart |
Öl-in-Wasser Emulsionen mit Saponinen
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
WO1999040936A2
(en)
|
1998-02-12 |
1999-08-19 |
American Cyanamid Company |
Pneumococcal and meningococcal vaccines formulated with interleukin-12
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
WO1999052549A1
(en)
|
1998-04-09 |
1999-10-21 |
Smithkline Beecham Biologicals S.A. |
Adjuvant compositions
|
|
HK1039072A1
(zh)
|
1998-05-07 |
2002-04-12 |
科里克萨有限公司 |
佐剂组合物及其使用方法
|
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
CN1263510C
(zh)
|
1998-08-19 |
2006-07-12 |
巴克斯特健康护理股份有限公司 |
多糖－蛋白质缀合物或寡糖－蛋白质缀合物、其制备方法及其应用
|
|
DK1126876T3
(da)
|
1998-10-16 |
2007-07-02 |
Glaxosmithkline Biolog Sa |
Adjuvanssystemer og vacciner
|
|
AU1626199A
(en)
|
1998-12-04 |
2000-06-26 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
A vi-repa conjugate vaccine for immunization against salmonella typhi
|
|
US20030130212A1
(en)
|
1999-01-14 |
2003-07-10 |
Rossignol Daniel P. |
Administration of an anti-endotoxin drug by intravenous infusion
|
|
US6551600B2
(en)
|
1999-02-01 |
2003-04-22 |
Eisai Co., Ltd. |
Immunological adjuvant compounds compositions and methods of use thereof
|
|
DE60013773T2
(de)
|
1999-02-03 |
2005-11-10 |
Biosante Pharmaceuticals, Inc. |
Methoden zur Herstellung von therapeutischen Kalziumphosphat Partikeln
|
|
IL145043A0
(en)
|
1999-03-19 |
2002-06-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
JP2002541808A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ， インコーポレイテッド |
ポリサッカリド結合体ワクチンのための組換えトキシンａタンパク質キャリア
|
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
EP1221971A2
(en)
|
1999-09-24 |
2002-07-17 |
SmithKline Beecham Biologics SA |
Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
|
|
CA2383110A1
(en)
|
1999-09-24 |
2001-03-29 |
Veronique Henderickx |
Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one non-ionic surfactant
|
|
UA77152C2
(en)
|
1999-09-25 |
2006-11-15 |
|
Method for stimulation of immune response using nucleic acid-containing immunostimulating compositions, method for treatment of cancer and method for treatment or prophylaxis of allergy or asthma
|
|
US20010044416A1
(en)
|
2000-01-20 |
2001-11-22 |
Mccluskie Michael J. |
Immunostimulatory nucleic acids for inducing a Th2 immune response
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
JP4341949B2
(ja)
|
2000-09-01 |
2009-10-14 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
アザ複素環式誘導体およびその治療的使用
|
|
PL211125B1
(pl)
|
2000-09-11 |
2012-04-30 |
Novartis Vaccines & Diagnostic |
Pochodne chinolinonu jako inhibitory kinazy tyrozynowej, kompozycje je zawierające i ich zastosowanie
|
|
CA2423487C
(en)
|
2000-09-26 |
2015-12-15 |
Hybridon, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
US6677348B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
|
US6660747B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
US6660735B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
UA75622C2
(en)
|
2000-12-08 |
2006-05-15 |
3M Innovative Properties Co |
Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
|
|
AT410798B
(de)
*
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
GB0107661D0
(en)
*
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
|
US20030035806A1
(en)
|
2001-05-11 |
2003-02-20 |
D'ambra Anello J. |
Novel meningitis conjugate vaccine
|
|
WO2003020875A2
(en)
|
2001-06-17 |
2003-03-13 |
D-Squared Biotechnologies, Inc. |
Staphylococci surface-exposed immunogenic polypeptides
|
|
CA2492823A1
(en)
|
2001-09-14 |
2003-03-27 |
Martin F. Bachmann |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
EP2196217A1
(en)
|
2001-09-14 |
2010-06-16 |
Cytos Biotechnology AG |
Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
US7321033B2
(en)
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
|
IL162137A0
(en)
|
2001-11-27 |
2005-11-20 |
Anadys Pharmaceuticals Inc |
D-ribofuranosylthiazolo -3-Ä4,5-dÜpyridimine nucl eosides and uses thereof
|
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
ATE447404T1
(de)
|
2002-03-29 |
2009-11-15 |
Novartis Vaccines & Diagnostic |
Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
|
|
AU2003233519A1
(en)
|
2002-05-29 |
2003-12-19 |
3M Innovative Properties Company |
Process for imidazo(4,5-c)pyridin-4-amines
|
|
EP1551228B1
(en)
|
2002-06-13 |
2012-10-03 |
New York University |
Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
|
|
CN1688573A
(zh)
|
2002-08-23 |
2005-10-26 |
希龙公司 |
糖原合成酶激酶3的吡咯基抑制剂
|
|
WO2004060308A2
(en)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Thiosemicarbazones as anti-virals and immunopotentiators
|
|
WO2004064759A2
(en)
|
2003-01-21 |
2004-08-05 |
Chiron Corporation |
Use of tryptanthrin compounds for immune potentiation
|
|
GB0301554D0
(en)
|
2003-01-23 |
2003-02-26 |
Molecularnature Ltd |
Immunostimulatory compositions
|
|
WO2004087153A2
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of organic compounds for immunopotentiation
|
|
CN1980692A
(zh)
|
2003-07-24 |
2007-06-13 |
麦克公司 |
用于诱导针对金黄色葡萄球菌的保护性免疫反应的多肽
|
|
US20060177462A1
(en)
|
2003-07-24 |
2006-08-10 |
Anderson Annaliesa S |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
RU2236257C1
(ru)
|
2003-09-15 |
2004-09-20 |
Косяков Константин Сергеевич |
Синтетический иммуноген для терапии и профилактики злоупотреблений наркотическими и психоактивными веществами
|
|
US7771726B2
(en)
|
2003-10-08 |
2010-08-10 |
New York University |
Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases
|
|
CA2555342A1
(en)
|
2004-02-18 |
2005-09-01 |
Merck & Co., Inc. |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
EP1725255A4
(en)
|
2004-02-27 |
2007-07-11 |
Merck & Co Inc |
POLYPEPTIDES FOR THE INDUCTION OF A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS
|
|
AU2005235080A1
(en)
|
2004-03-31 |
2005-11-03 |
New York University |
Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases
|
|
EP1742659B1
(en)
|
2004-04-05 |
2013-03-13 |
Pah Usa 15 Llc |
Microfluidized oil-in-water emulsions and vaccine compositions
|
|
EP1753441A2
(en)
|
2004-05-25 |
2007-02-21 |
Merck & Co., Inc. |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
CA2579225A1
(en)
|
2004-09-17 |
2006-03-30 |
Merck & Co., Inc. |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
GB0421079D0
(en)
*
|
2004-09-22 |
2004-10-27 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
EP2340848A3
(en)
*
|
2004-10-21 |
2011-09-14 |
Wyeth LLC |
Immunogenic compositions of Staphylococcus epidermidis polypeptide and polynucleotide antigens
|
|
US7718182B2
(en)
|
2005-01-21 |
2010-05-18 |
Merck Sharp & Dohme Corp. |
Polypeptides for inducing a protective immune response against Staphylococcus aureus
|
|
US20060228368A1
(en)
|
2005-04-07 |
2006-10-12 |
Nabi Biopharmaceuticals |
Method of protecting against staphylococcal infection
|
|
US20060228369A1
(en)
|
2005-04-11 |
2006-10-12 |
Program For Appropriate Technology In Health |
Stabilization and preservation of temperature-sensitive vaccines
|
|
US7691368B2
(en)
|
2005-04-15 |
2010-04-06 |
Merial Limited |
Vaccine formulations
|
|
KR20130122810A
(ko)
|
2005-06-27 |
2013-11-08 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신 제조 방법
|
|
US8703095B2
(en)
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
|
GB0526038D0
(en)
|
2005-12-21 |
2006-02-01 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
FR2896162B1
(fr)
|
2006-01-13 |
2008-02-15 |
Sanofi Pasteur Sa |
Emulsion huile dans eau thermoreversible
|
|
EP1998800A2
(en)
|
2006-01-18 |
2008-12-10 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
|
AR060187A1
(es)
|
2006-03-30 |
2008-05-28 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica
|
|
MY148405A
(en)
|
2006-03-30 |
2013-04-30 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
EP2719397A1
(en)
|
2006-06-12 |
2014-04-16 |
GlaxoSmithKline Biologicals SA |
Use of alpha-toxin for treating and preventing staphylococcus infections
|
|
CN101522218B
(zh)
|
2006-10-12 |
2012-09-26 |
葛兰素史密丝克莱恩生物有限公司 |
包含水包油乳液佐剂的疫苗
|
|
CA2667788A1
(en)
|
2006-10-30 |
2008-12-18 |
The University Of Western Ontario |
Staphylococcus aureus specific anti-infectives
|
|
DE102006062398A1
(de)
|
2006-12-20 |
2008-06-26 |
Edi (Experimentelle & Diagnostische Immunologie) Gmbh |
Verfahren zur Erkennung und/oder Charakterisierung zellulärer Aktivitätsmuster, Verwendung von Toll-like-Rezeptor-Liganden (TLR-Liganden) und ein Kit
|
|
GB0700136D0
(en)
*
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
|
EP2164869A2
(en)
|
2007-05-31 |
2010-03-24 |
Merck Sharp & Dohme Corp. |
Antigen-binding proteins targeting s. aureus orf0657n
|
|
KR20100072228A
(ko)
*
|
2007-08-31 |
2010-06-30 |
유니버시티 오브 시카고 |
스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
|
|
EP2344189B1
(en)
|
2008-09-30 |
2018-05-30 |
University of Maryland, Baltimore |
Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens
|
|
EP2208787A1
(en)
|
2009-01-19 |
2010-07-21 |
Université de Liège |
A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
|
|
WO2010119343A2
(en)
*
|
2009-04-14 |
2010-10-21 |
Novartis Ag |
Compositions for immunising against staphylococcus aureus
|